Sofya A. Tsarkova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sofya A. Tsarkova has a total of 158 co-authors. Here are the top co-authors by number of shared publications:
- Alexander M. Vavilov
Kemerovo State Medical University
6 shared publications Царькова Софья Анатольевна
Уральский государственный медицинский университет
6 shared publications- Vera P. Vavilova
Kemerovo State Medical University
4 shared publications - Zhanna A. Tsareva
Children’s City Clinical Hospital No. 9
4 shared publications - Natalia Anatolievna Geppe
Sechenov First Moscow State Medical University (Sechenov University)
3 shared publications - Natalia G. Kolosova
Sechenov First Moscow State Medical University (Sechenov University)
3 shared publications
Latest Publications
- 25 December 2025
- Published by ECO-Vector LLC (Publications) in Perm Medical Journal
- Vol. 42 (6)
Cardiovascular disorders in children as a long-term outcome of bronchopulmonary dysplasia
Objective. To assess the frequency and characteristics of cardiovascular disorders (CVD) in 2-year-old children with a history of bronchopulmonary dysplasia (BPD). Materials and methods. A retrospective study was conducted based on the analysis of 137 outpatient records of children discharged from perinatal centers in Yekaterinburg. The study included patients with confirmed BPD. Cardiovascular parameters, physical and psychomotor development, vision, and neurological status were evaluated on the basis of the data recorded in the patients` charts. The children were categorized into CVD risk groups: low (41.7 %), medium (43.9 %), and high (14.2 %). The analysis encompassed echocardiography (EchoCG), electrocardiography (ECG), renal and thymus ultrasound examination results, as well as findings from clinical examination by pediatric cardiologists, ophthalmologists and neurologists. Physical and psychomotor development was assessed using the Griffiths scale and the Denver Development Screening Test II (DDST-II). Methods of statistical analysis. Statistical analysis was performed using Microsoft Excel 2019 and SPSS for Windows, version 20.0. Qualitative data are presented as absolute numbers and percentages; for their comparison, the χ2 test with Yates`s correction and Fisher`s exact test for small sample sizes were applied. The normality of quantitative data distribution was assessed using the Shapiro-Wilk test. For non-normally distributed data, results are presented as median and interquartile range (Me (25 %–75 %)). The Mann – Whitney U test was used to compare quantitative variables between groups. Statistically significant differences were considered with p 0,05. Results. 2-year-old children in the high-cardiovascular risk group demonstrated a higher frequency of deviations in physical and psychomotor developmental, rhythm disturbances, myocardial repolarization abnormalities, and signs of neurological impairments. These changes were less pronounced in the medium- and low-risk groups. All major differences between groups were statistically significant. The frequency of myopia and astigmatism did not differ between the study groups. The high-risk group also showed a greater prevalence of signs of hypertensive-hydrocephalic syndrome and chronic bronchopulmonary diseases. All major differences between the groups were statistically significant. Conclusions. By the age of 2 years, a high frequency of CVD was identified in children with a history of BPD (66.4 %). The severity of CVD was dependent on the early prognostic risk level: the most severe impairments were observed in the high-risk group, whereas the children in the low- and medium -risk groups had significantly less pronounced changes. The prognostic risk established in the perinatal period influences subsequent outcomes. Thus, the CVD outcomes in 2-year-old children with a history of BPD confirm the critical importance of early risk prognosis for determining the strategy for their further long-term follow-up and individualized management.
- 25 December 2025
- Published by ECO-Vector LLC (Publications) in Perm Medical Journal
- Vol. 42 (6)
Cardiovascular disorders in children as a long-term outcome of bronchopulmonary dysplasia
Objective. To assess the frequency and characteristics of cardiovascular disorders (CVD) in 2-year-old children with a history of bronchopulmonary dysplasia (BPD). Materials and methods. A retrospective study was conducted based on the analysis of 137 outpatient records of children discharged from perinatal centers in Yekaterinburg. The study included patients with confirmed BPD. Cardiovascular parameters, physical and psychomotor development, vision, and neurological status were evaluated on the basis of the data recorded in the patients` charts. The children were categorized into CVD risk groups: low (41.7 %), medium (43.9 %), and high (14.2 %). The analysis encompassed echocardiography (EchoCG), electrocardiography (ECG), renal and thymus ultrasound examination results, as well as findings from clinical examination by pediatric cardiologists, ophthalmologists and neurologists. Physical and psychomotor development was assessed using the Griffiths scale and the Denver Development Screening Test II (DDST-II). Methods of statistical analysis. Statistical analysis was performed using Microsoft Excel 2019 and SPSS for Windows, version 20.0. Qualitative data are presented as absolute numbers and percentages; for their comparison, the χ2 test with Yates`s correction and Fisher`s exact test for small sample sizes were applied. The normality of quantitative data distribution was assessed using the Shapiro-Wilk test. For non-normally distributed data, results are presented as median and interquartile range (Me (25 %–75 %)). The Mann – Whitney U test was used to compare quantitative variables between groups. Statistically significant differences were considered with p 0,05. Results. 2-year-old children in the high-cardiovascular risk group demonstrated a higher frequency of deviations in physical and psychomotor developmental, rhythm disturbances, myocardial repolarization abnormalities, and signs of neurological impairments. These changes were less pronounced in the medium- and low-risk groups. All major differences between groups were statistically significant. The frequency of myopia and astigmatism did not differ between the study groups. The high-risk group also showed a greater prevalence of signs of hypertensive-hydrocephalic syndrome and chronic bronchopulmonary diseases. All major differences between the groups were statistically significant. Conclusions. By the age of 2 years, a high frequency of CVD was identified in children with a history of BPD (66.4 %). The severity of CVD was dependent on the early prognostic risk level: the most severe impairments were observed in the high-risk group, whereas the children in the low- and medium -risk groups had significantly less pronounced changes. The prognostic risk established in the perinatal period influences subsequent outcomes. Thus, the CVD outcomes in 2-year-old children with a history of BPD confirm the critical importance of early risk prognosis for determining the strategy for their further long-term follow-up and individualized management.
- Open Access
- 8 January 2025
- Published by ECO-Vector LLC in Russian Family Doctor
- Vol. 29 (1) , 27-34
Prediction of cardiovascular risk in infants with bronchopulmonary dysplasia
BACKGROUND: Respiratory, neurological and other outcomes of bronchopulmonary dysplasia in infants are well documented. However, the incidence and severity of cardiovascular abnormalities require further research. AIM: The aim of the study was to establish cardiovascular risk criteria in infants with bronchopulmonary dysplasia and develop a mathematical model to predict cardiovascular abnormalities. METHODS: A total of 1931 perinatal discharge records were analyzed. The final analysis included 274 source records. The main group was divided into two subgroups: 91 infants with cardiovascular abnormalities and 46 infants without cardiovascular abnormalities. The analysis included 225 parameters of perinatal history, laboratory and functional diagnostic tests. Discriminant and correlation analyses were performed using SPSS for statistical data processing. RESULTS: Cardiovascular abnormalities were found in 66.4% of infants with bronchopulmonary dysplasia at 3 months of age and were represented by morphological changes such as functional patent foramen ovale, patent ductus arteriosus, and prolonged exposure to these conditions. Circulatory failure, transient pulmonary hypertension and combinations of cardiovascular abnormalities were reported. Nine significant cardiovascular risk factors were identified, such as patent ductus arteriosus, gestational age ≤ 32 weeks, use of two doses of surfactant, time of prenatal care enrollment, duration of mechanical ventilation and oxygen dependence 28 days, grade III–IV cerebral ischemia, severe retinopathy, body weight 1 kg. A formula was developed to predict a low, moderate, or high cardiovascular risk (98%). CONCLUSION: In infants with bronchopulmonary dysplasia at 3 months of age, estimated individual cardiovascular risk helps differentiate the approach to preventing heart and blood vessel damage.
- 8 January 2025
- Published by ECO-Vector LLC in Russian Family Doctor
- Vol. 29 (1) , 27-34
Open AccessPrediction of cardiovascular risk in infants with bronchopulmonary dysplasia
BACKGROUND: Respiratory, neurological and other outcomes of bronchopulmonary dysplasia in infants are well documented. However, the incidence and severity of cardiovascular abnormalities require further research. AIM: The aim of the study was to establish cardiovascular risk criteria in infants with bronchopulmonary dysplasia and develop a mathematical model to predict cardiovascular abnormalities. METHODS: A total of 1931 perinatal discharge records were analyzed. The final analysis included 274 source records. The main group was divided into two subgroups: 91 infants with cardiovascular abnormalities and 46 infants without cardiovascular abnormalities. The analysis included 225 parameters of perinatal history, laboratory and functional diagnostic tests. Discriminant and correlation analyses were performed using SPSS for statistical data processing. RESULTS: Cardiovascular abnormalities were found in 66.4% of infants with bronchopulmonary dysplasia at 3 months of age and were represented by morphological changes such as functional patent foramen ovale, patent ductus arteriosus, and prolonged exposure to these conditions. Circulatory failure, transient pulmonary hypertension and combinations of cardiovascular abnormalities were reported. Nine significant cardiovascular risk factors were identified, such as patent ductus arteriosus, gestational age ≤ 32 weeks, use of two doses of surfactant, time of prenatal care enrollment, duration of mechanical ventilation and oxygen dependence 28 days, grade III–IV cerebral ischemia, severe retinopathy, body weight 1 kg. A formula was developed to predict a low, moderate, or high cardiovascular risk (98%). CONCLUSION: In infants with bronchopulmonary dysplasia at 3 months of age, estimated individual cardiovascular risk helps differentiate the approach to preventing heart and blood vessel damage.
- Open Access
- 1 January 2025
- Published by Geotar-Media Publishing Group in Infectious diseases: News, Opinions, Training
- Vol. 14 (4)
Consensus of Experts on Immunoprophylaxis of Respiratory Infections from the XIV International Educational Consensus on Respiratory Medicine in Pediatrics
Согласованное мнение экспертов по вопросам иммунопрофилактики респираторных инфекций XIV Международного образовательного консенсуса по респираторной
- 1 January 2025
- Published by Geotar-Media Publishing Group in Infectious diseases: News, Opinions, Training
- Vol. 14 (4)
Open AccessConsensus of Experts on Immunoprophylaxis of Respiratory Infections from the XIV International Educational Consensus on Respiratory Medicine in Pediatrics
Согласованное мнение экспертов по вопросам иммунопрофилактики респираторных инфекций XIV Международного образовательного консенсуса по респираторной
- Open Access
- 26 December 2024
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- Vol. 35 (1) , 110-117
E-cigarette, or Vaping, product use-Associated Lung Injury (EVALI): a diagnosis of exclusion
EVALI (e-cigarette or vaping product use-associated lung injury) is a relatively new disease with complex differential diagnosis, as it mimics the clinical and pathological picture of various pulmonary diseases. The diversity of clinical manifestations of the disease described in the literature necessitates for treating EVALI as a diagnosis of exclusion and requires accumulation and understanding of the data to develop effective methods for diagnosis and patient management. The aim of the work was to present a clinical observation of vaping-associated lung injury (EVALI) in an adolescent as a diagnosis of exclusion. Conclusion. The presented clinical case demonstrates vaping-associated lung injury in a 15-year-old girl and the importance of high-quality collection of medical history for timely and correct diagnosis.
- 26 December 2024
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- Vol. 35 (1) , 110-117
Open AccessE-cigarette, or Vaping, product use-Associated Lung Injury (EVALI): a diagnosis of exclusion
EVALI (e-cigarette or vaping product use-associated lung injury) is a relatively new disease with complex differential diagnosis, as it mimics the clinical and pathological picture of various pulmonary diseases. The diversity of clinical manifestations of the disease described in the literature necessitates for treating EVALI as a diagnosis of exclusion and requires accumulation and understanding of the data to develop effective methods for diagnosis and patient management. The aim of the work was to present a clinical observation of vaping-associated lung injury (EVALI) in an adolescent as a diagnosis of exclusion. Conclusion. The presented clinical case demonstrates vaping-associated lung injury in a 15-year-old girl and the importance of high-quality collection of medical history for timely and correct diagnosis.
- Open Access
- 18 October 2024
- Published by Ural State Medical University in Ural Medical Journal
- Vol. 23 (5) , 143-156
Bronchopulmonary Dysplasia in Children. An Up-to-Date View of Disease Outcomes
Introduction. Bronchopulmonary dysplasia (BPD) is a chronic neonatal lung disease, with oxygen dependence by 36 weeks post conceptual age (PCA). Over the past decade, the frequency of the disease has increased. More and more modern scientific data are published that BPD has an adverse effect not just the development of the lungs, but also on the cardiovascular system. There is a large amount of information in the literature about the outcomes of BPD, but there is not enough information about the consequences of cardiovascular disorders in children with a history of BPD. Lack of clear criteria to predict and prevent to demonstrate cardiovascular disorders, were the basis for a detailed study of the literature concerning this issue.Purpose of the study based on study of the results of studies by local and foreign authors, to analyze the nature of cardiovascular disorders in children with a history of BPD, and to determine directions for more detailed scientific and practical search for a solution to this problem.Materials and methods. Research articles were searched for keywords “bronchopulmonary dysplasia” and “сardiovascular disorders” in the PubMed, UpToDate, Google Scholar databases, eLibrary.ru. At least 80 publications have been extracted from search results for simplification. Analyses of the results of studies by local and foreign authors on outcomes, BPD, including cardiovascular disorders, was carried out.Results and discussion. At the moment, the outcomes of BPD are well understood, while few information on cardiovascular disorders and possible prognosis for children who have undergone BPD.Conclusion. Cardiovascular disorders in children with a history of BPD are a pressing problem in pediatric practice. The presented literature review summarizes the information accumulated over several years on the outcomes of cardiovascular changes and determines the direction for further study of the problem, involving pediatricians and doctors of other specialties in order to identify groups at increased risk for the development of these diseases in children.
- 18 October 2024
- Published by Ural State Medical University in Ural Medical Journal
- Vol. 23 (5) , 143-156
Open AccessBronchopulmonary Dysplasia in Children. An Up-to-Date View of Disease Outcomes
Introduction. Bronchopulmonary dysplasia (BPD) is a chronic neonatal lung disease, with oxygen dependence by 36 weeks post conceptual age (PCA). Over the past decade, the frequency of the disease has increased. More and more modern scientific data are published that BPD has an adverse effect not just the development of the lungs, but also on the cardiovascular system. There is a large amount of information in the literature about the outcomes of BPD, but there is not enough information about the consequences of cardiovascular disorders in children with a history of BPD. Lack of clear criteria to predict and prevent to demonstrate cardiovascular disorders, were the basis for a detailed study of the literature concerning this issue.Purpose of the study based on study of the results of studies by local and foreign authors, to analyze the nature of cardiovascular disorders in children with a history of BPD, and to determine directions for more detailed scientific and practical search for a solution to this problem.Materials and methods. Research articles were searched for keywords “bronchopulmonary dysplasia” and “сardiovascular disorders” in the PubMed, UpToDate, Google Scholar databases, eLibrary.ru. At least 80 publications have been extracted from search results for simplification. Analyses of the results of studies by local and foreign authors on outcomes, BPD, including cardiovascular disorders, was carried out.Results and discussion. At the moment, the outcomes of BPD are well understood, while few information on cardiovascular disorders and possible prognosis for children who have undergone BPD.Conclusion. Cardiovascular disorders in children with a history of BPD are a pressing problem in pediatric practice. The presented literature review summarizes the information accumulated over several years on the outcomes of cardiovascular changes and determines the direction for further study of the problem, involving pediatricians and doctors of other specialties in order to identify groups at increased risk for the development of these diseases in children.
- Open Access
- 8 June 2024
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 1,p. 55-63
Post-COVID syndrome in children: the results of a retrospective multicenter cross-sectional study
Background. Currently, there are no multicenter studies to determine the prevalence and incidence of symptoms of post-COVID syndrome (PCS) in children in different age groups, to develop consistent observation algorithms, and to identify therapy options. Aim. To establish the risk factors for PCS in children and its CSs in the Russian Federation. Materials and methods. A retrospective multicenter cross-sectional study was conducted. The initial stage of the study included 565 children at 7.6±0.17 months after the new coronavirus infection (NCVI) who were on outpatient or inpatient observation in different regions of Russia from November 2022 to May 2023. Patients were selected from 9 regions of the Russian Federation, such as Izhevsk, Kemerovo, Moscow, Omsk and Omsk region, Yekaterinburg and Sverdlovsk region, Ufa, Tyumen, Samara, Naberezhnye Chelny. All patients were offered a questionnaire. The questionnaire was developed and adapted based on the British and American consensus on the PCS, which included an assessment of the history, severity of the disease, clinical form of acute NCVI, therapy in the acute period of NCVI, and the presence of comorbidities. In addition, the course of acute NCVI and symptoms 3 months after the disease were evaluated by the following groups of CS: asthenia, respiratory disorders (RD), gastrointestinal disorders (GI), neurocognitive disorders (NCD), skin/adnexal lesions, olfactory/taste disorders, autonomic dysfunction (AD), anxiety. Of the 565 questionnaires received, 435 (76.9%) met the inclusion criteria and were available for subsequent analysis. The mean age was 9.0±0.25 years. Results. During the acute period of the NCVI, asthenic syndrome (AS), RD and NCD, anxiety symptoms, olfactory/taste disorders, manifestations of AD, GI and skin/adnexal lesions were most often detected. Our study showed that after 3 months or more after NKVI, AS, NCD, and RD recurred in almost half of the observed children (53.1, 49.0 and 47.8%, respectively), anxiety was detected in 42,5% of cases, in more than 1/5 of children, AD, olfactory/taste and gastrointestinal disorders, in 14.3% skin/appendage lesions. Even 90 days after recovery from NCVI, more than half of patients reported impaired functionality, and most children had multiple complaints, which significantly impaired their quality of life. The risk of developing certain manifestations of PCS was increased in patients with comorbidities. Conclusion. The study found that PCS developed in patients with severe, moderate, and mild acute COVID-19. The presence of comorbidities (allergic, neurological diseases, ENT disorders) statistically significantly increased the risk of PCS. The study's results further confirm the importance of continuous monitoring of NKVI sequelae in children and adolescents and the need for follow-up in children recovered from NKVI for 3-12 months.
- 8 June 2024
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 1,p. 55-63
Open AccessPost-COVID syndrome in children: the results of a retrospective multicenter cross-sectional study
Background. Currently, there are no multicenter studies to determine the prevalence and incidence of symptoms of post-COVID syndrome (PCS) in children in different age groups, to develop consistent observation algorithms, and to identify therapy options. Aim. To establish the risk factors for PCS in children and its CSs in the Russian Federation. Materials and methods. A retrospective multicenter cross-sectional study was conducted. The initial stage of the study included 565 children at 7.6±0.17 months after the new coronavirus infection (NCVI) who were on outpatient or inpatient observation in different regions of Russia from November 2022 to May 2023. Patients were selected from 9 regions of the Russian Federation, such as Izhevsk, Kemerovo, Moscow, Omsk and Omsk region, Yekaterinburg and Sverdlovsk region, Ufa, Tyumen, Samara, Naberezhnye Chelny. All patients were offered a questionnaire. The questionnaire was developed and adapted based on the British and American consensus on the PCS, which included an assessment of the history, severity of the disease, clinical form of acute NCVI, therapy in the acute period of NCVI, and the presence of comorbidities. In addition, the course of acute NCVI and symptoms 3 months after the disease were evaluated by the following groups of CS: asthenia, respiratory disorders (RD), gastrointestinal disorders (GI), neurocognitive disorders (NCD), skin/adnexal lesions, olfactory/taste disorders, autonomic dysfunction (AD), anxiety. Of the 565 questionnaires received, 435 (76.9%) met the inclusion criteria and were available for subsequent analysis. The mean age was 9.0±0.25 years. Results. During the acute period of the NCVI, asthenic syndrome (AS), RD and NCD, anxiety symptoms, olfactory/taste disorders, manifestations of AD, GI and skin/adnexal lesions were most often detected. Our study showed that after 3 months or more after NKVI, AS, NCD, and RD recurred in almost half of the observed children (53.1, 49.0 and 47.8%, respectively), anxiety was detected in 42,5% of cases, in more than 1/5 of children, AD, olfactory/taste and gastrointestinal disorders, in 14.3% skin/appendage lesions. Even 90 days after recovery from NCVI, more than half of patients reported impaired functionality, and most children had multiple complaints, which significantly impaired their quality of life. The risk of developing certain manifestations of PCS was increased in patients with comorbidities. Conclusion. The study found that PCS developed in patients with severe, moderate, and mild acute COVID-19. The presence of comorbidities (allergic, neurological diseases, ENT disorders) statistically significantly increased the risk of PCS. The study's results further confirm the importance of continuous monitoring of NKVI sequelae in children and adolescents and the need for follow-up in children recovered from NKVI for 3-12 months.
- Open Access
- 26 March 2024
- Published by LLC Global Media Technology in Archives of Pediatrics and Pediatric Surgery
- Vol. 2 (1) , 79-87
Study of the effectiveness and safety of a combination of a hypertonic solution and high molecular weight hyaluronic acid (Ingasalin® 3%) in the form of inhalation in the treatment of acute bronchitis against the background of acute respiratory infections in children 3-7 years old
Исследование эффективности и безопасности комбинации гипертонического раствора и высокомолекулярной гиалуроновой кислоты (Ингасалин® 3%) в виде ингаляции в терапии острого бронхита на фоне ОРИ у детей 3-7 лет
- 26 March 2024
- Published by LLC Global Media Technology in Archives of Pediatrics and Pediatric Surgery
- Vol. 2 (1) , 79-87
Open AccessStudy of the effectiveness and safety of a combination of a hypertonic solution and high molecular weight hyaluronic acid (Ingasalin® 3%) in the form of inhalation in the treatment of acute bronchitis against the background of acute respiratory infections in children 3-7 years old
Исследование эффективности и безопасности комбинации гипертонического раствора и высокомолекулярной гиалуроновой кислоты (Ингасалин® 3%) в виде ингаляции в терапии острого бронхита на фоне ОРИ у детей 3-7 лет
- Open Access
- 22 December 2023
- Published by Paediatrician Publishers LLC in Annals of the Russian academy of medical sciences
- Vol. 78 (5) , 455-466
Modern Possibilities for Predicting Systemic Manifestations of Food Allergy Based on the Results of a Prospective Cohort Study
Background. Food allergies (FA) are a common problem in childhood. Food anaphylaxis (FAN) can be life threatening. In this regard, it is reasonable to study clinical and anamnestic data and factors that can influence FAN formation in order to develop mathematical models of prognosis aimed at reducing acute episodes of FA, including FAN. Aims — to establish clinical and pathogenetic factors contributing to the formation of systemic manifestations of FA in children and to develop a mathematical method for predicting severe systemic reactions to food. Methods. A prospective cohort open study included 76 children (5.12 ± 3.74 years) suffering from persistent FA with a history of FAN episodes. The comparison group included 134 children (7.18 ± 2.52 years old) who had atopic diseases, local manifestations of FA, but without systemic reactions to food. Illness and life history, presence and severity of concomitant diseases were studied, general clinical and immunological studies were performed (in blood serum and oral cavity). Results. Based on the data in 210 children, the odds ratio (OR) of systemic FA formation was calculated, where the risks were: caesarean section (OR 1.8; 95% CI [1.02; 3.01]; p 0.05), immediate allergic reactions to food (OR 3.3; 95% CI [1.47; 7.39]; p 0.05), maternal anemia during pregnancy (OR 3.5; 95% CI [1.83; 6.57]; p 0.05), allergic diseases in siblings (OR 4.8; 95% CI [2.04; 11.18]; p 0.05), presence of atopic dermatitis (AD) (OR 3.7; 95% CI [1.77; 7.68]; p 0.05), allergy to cow’s milk proteins (CMP) (OR 7.8; 95% CI [4.31; 14.24]; p 0.05), clinical need for introduction of amino acid formulae (OR 100.8; 95% CI [13.37; 760.67]; p 0.05). A mathematical method was found for predicting FAN with a decision rule Y ≥ 0.35, with a forecast efficiency of up to 90% when using a linear regression equation: Y = 0.0518 + 0.2983×A1 + 0.2390 × A2 + 0.4793×A3 – 0.0037 × A4 + 0.0002 × A5, where A1 is CMP as the first allergic product (0 or 1), A2 is rapid onset of reaction (0 or 1), A3 is amino acid formulae use (0 or 1), A4 is age of wheezing (in months), A5 is eosinophils (cells/µl). Conclusions. Symptoms of AD and severe FA to CMP, requiring amino acid formulae introduction, should be considered as alarming anamnestic data for predicting possible FAN episodes, if the child has immediate type of FA, the mother’s pregnancy proceeded against the background of anemia, delivery was carried out operatively way and there are already children with atopic diseases in the family. The proposed mathematical method for predicting FAN makes it possible to determine probability of severe allergic reactions to food in children with an efficiency of up to 90%.
- 22 December 2023
- Published by Paediatrician Publishers LLC in Annals of the Russian academy of medical sciences
- Vol. 78 (5) , 455-466
Open AccessModern Possibilities for Predicting Systemic Manifestations of Food Allergy Based on the Results of a Prospective Cohort Study
Background. Food allergies (FA) are a common problem in childhood. Food anaphylaxis (FAN) can be life threatening. In this regard, it is reasonable to study clinical and anamnestic data and factors that can influence FAN formation in order to develop mathematical models of prognosis aimed at reducing acute episodes of FA, including FAN. Aims — to establish clinical and pathogenetic factors contributing to the formation of systemic manifestations of FA in children and to develop a mathematical method for predicting severe systemic reactions to food. Methods. A prospective cohort open study included 76 children (5.12 ± 3.74 years) suffering from persistent FA with a history of FAN episodes. The comparison group included 134 children (7.18 ± 2.52 years old) who had atopic diseases, local manifestations of FA, but without systemic reactions to food. Illness and life history, presence and severity of concomitant diseases were studied, general clinical and immunological studies were performed (in blood serum and oral cavity). Results. Based on the data in 210 children, the odds ratio (OR) of systemic FA formation was calculated, where the risks were: caesarean section (OR 1.8; 95% CI [1.02; 3.01]; p 0.05), immediate allergic reactions to food (OR 3.3; 95% CI [1.47; 7.39]; p 0.05), maternal anemia during pregnancy (OR 3.5; 95% CI [1.83; 6.57]; p 0.05), allergic diseases in siblings (OR 4.8; 95% CI [2.04; 11.18]; p 0.05), presence of atopic dermatitis (AD) (OR 3.7; 95% CI [1.77; 7.68]; p 0.05), allergy to cow’s milk proteins (CMP) (OR 7.8; 95% CI [4.31; 14.24]; p 0.05), clinical need for introduction of amino acid formulae (OR 100.8; 95% CI [13.37; 760.67]; p 0.05). A mathematical method was found for predicting FAN with a decision rule Y ≥ 0.35, with a forecast efficiency of up to 90% when using a linear regression equation: Y = 0.0518 + 0.2983×A1 + 0.2390 × A2 + 0.4793×A3 – 0.0037 × A4 + 0.0002 × A5, where A1 is CMP as the first allergic product (0 or 1), A2 is rapid onset of reaction (0 or 1), A3 is amino acid formulae use (0 or 1), A4 is age of wheezing (in months), A5 is eosinophils (cells/µl). Conclusions. Symptoms of AD and severe FA to CMP, requiring amino acid formulae introduction, should be considered as alarming anamnestic data for predicting possible FAN episodes, if the child has immediate type of FA, the mother’s pregnancy proceeded against the background of anemia, delivery was carried out operatively way and there are already children with atopic diseases in the family. The proposed mathematical method for predicting FAN makes it possible to determine probability of severe allergic reactions to food in children with an efficiency of up to 90%.
- Open Access
- 30 June 2023
- Published by Ural State Medical University in Ural Medical Journal
- Vol. 22 (3) , 137-144
Pediatric chest pain and synopsis is a current problem of pediatrics
Introduction. Cardialgia is a common reason for seeking medical care in the practice of the pediatrician and pediatric cardiologist. The combination of cardialgia and syncope in children can pose a health risk, leading to possible injuries, and is a factor of fear and anxiety in these families. Insufficient information on the pathophysiological basis of the development of cardialgia and syncope in children and the absebce of clear criteria for their prognosis and prevention were the reasons for a detailed study of the literature related to this issue.The aim of the work was to systematize the current literary data on the causes of cardialgia and syncope in children and to determine directions for further study of the problem to improve monitoring by pediatricians and pediatric cardiologists.Materials and methods. We searched for scientific articles using the keywords pediatric chest pain and syncope in the Pubmed, UpToDate 2022, Customer Service, and RSCI databases. Sixty publications were selected for analysis.Results and discussion. Cardialgia is pain in the heart region, which in combination with fainting can be a symptom of a large number of diseases, which determines the different approach of medical specialists involved in the treatment of diseases of the cardiovascular system, and requires a special diagnosis. Cardialgia is characterized by polymorphism of both complaints and subjective sensations, and objective data. All this is caused by a variety of etiopathogenesis of this symptom.Conclusion. Cardialgia is a current problem in pediatric practice. This literature review summarizes the information accumulated over several years on the diagnosis of cardialgia and syncope in children and determines the trajectory of further study of the problem.
- 30 June 2023
- Published by Ural State Medical University in Ural Medical Journal
- Vol. 22 (3) , 137-144
Open AccessPediatric chest pain and synopsis is a current problem of pediatrics
Introduction. Cardialgia is a common reason for seeking medical care in the practice of the pediatrician and pediatric cardiologist. The combination of cardialgia and syncope in children can pose a health risk, leading to possible injuries, and is a factor of fear and anxiety in these families. Insufficient information on the pathophysiological basis of the development of cardialgia and syncope in children and the absebce of clear criteria for their prognosis and prevention were the reasons for a detailed study of the literature related to this issue.The aim of the work was to systematize the current literary data on the causes of cardialgia and syncope in children and to determine directions for further study of the problem to improve monitoring by pediatricians and pediatric cardiologists.Materials and methods. We searched for scientific articles using the keywords pediatric chest pain and syncope in the Pubmed, UpToDate 2022, Customer Service, and RSCI databases. Sixty publications were selected for analysis.Results and discussion. Cardialgia is pain in the heart region, which in combination with fainting can be a symptom of a large number of diseases, which determines the different approach of medical specialists involved in the treatment of diseases of the cardiovascular system, and requires a special diagnosis. Cardialgia is characterized by polymorphism of both complaints and subjective sensations, and objective data. All this is caused by a variety of etiopathogenesis of this symptom.Conclusion. Cardialgia is a current problem in pediatric practice. This literature review summarizes the information accumulated over several years on the diagnosis of cardialgia and syncope in children and determines the trajectory of further study of the problem.
- Open Access
- 18 January 2023
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 4,p. 322-330
One of the possibilities of optimizing the therapy of a new coronavirus infection in children with the inclusion of an extract from marshmallow root, chamomile flowers, horsetail grass, walnut leaves, yarrow grass, oak bark and dandelion grass: prospective open comparative cohort study
Background. The issue of acute respiratory infections in children remains one of the most urgent. Therefore, in the pandemic due to the new coronavirus SARS-CoV-2, the search for effective treatment regimens for this disease is necessary. Aim. To compare the change of clinical symptoms, terms of virus elimination and disease-related economic cost as well as utilization of outpatient healthcare services in children with new coronavirus infection using the herbal medicine Tonsilgon N, oral solution, added to standard therapy. Materials and methods. A prospective open comparative cohort study of the effectiveness of coronavirus infection treatment in children using the standard of care alone and the standard of care with Tonsilgon N was conducted. Group 1 children (n=720) received the standard therapy for COVID-19 and Tonsilgon N oral solution for 10 days, and group 2 patients (n=670) only received the standard therapy for COVID-19. Treatment efficacy was evaluated according to the change of clinical symptoms in the observed patients, the results of SARS-CoV-2 coronavirus RNA detection in nasopharyngeal smears by polymerase chain reaction, the utilization of healthcare services, temporary disability of parents, the economic cost of the disease. Results. Studied patients of both groups had a typical clinical presentation of mild to moderate severity new coronavirus infection. Fatigue (96.599.7%) and sore throat (93.893.9%) were the most frequent symptoms. Posterior pharynx hyperemia was noted slightly less frequently. Low-grade fever was noted in 85.786.6% of the patients, equally often in patients of both groups. The significant therapeutic effect of the herbal medicine containing extract of marshmallow root, chamomile flowers, horsetail herb, walnut leaf, yarrow herb, oak bark, and dandelion herb includes reducing the time of sore throat relief in 93.2% of main group patients. After 10 days of treatment, sore throat persisted only in 6.8% of group 1 and 68.1% of group 2 patients (p=0.0001). These results indicate that Tonsilgon combined with standard of care is a promising way to improve the quality of life of children with the new coronavirus infection. The addition of Tonsilgon in therapy for new coronavirus infection in children shortens the time of acute inflammation resolution and reduces the duration of inflammatory intoxication. The therapy of new coronavirus infection under the provisional guidelines leads to a reduction in the time for clinical recovery and virus elimination in children and adolescents (p=0.0001) and a decrease in the utilization of outpatient healthcare services are observed: 3/4 of Group 1 patients and 1/2 of Group 2 patients (p=0.0001) applied for medical help twice during the observation period, 14.6% of Group 1 patients and 29.1% of Group 2 parents applied for medical help more than 3 times (p=0.0001). Thus, the direct and indirect economic costs of the disease decreased. The lower economic cost for parents of children in Group 1 was due to less need for medication and a lower reduction in family income due to temporary disability compared to those for parents in Group 2 (p=0.0001). No treatment-related adverse events was reported. Conclusion. The above data indicate that Tonsilgon therapy is an affordable way to optimize the treatment of new coronavirus infection in children.
- 18 January 2023
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 4,p. 322-330
Open AccessOne of the possibilities of optimizing the therapy of a new coronavirus infection in children with the inclusion of an extract from marshmallow root, chamomile flowers, horsetail grass, walnut leaves, yarrow grass, oak bark and dandelion grass: prospective open comparative cohort study
Background. The issue of acute respiratory infections in children remains one of the most urgent. Therefore, in the pandemic due to the new coronavirus SARS-CoV-2, the search for effective treatment regimens for this disease is necessary. Aim. To compare the change of clinical symptoms, terms of virus elimination and disease-related economic cost as well as utilization of outpatient healthcare services in children with new coronavirus infection using the herbal medicine Tonsilgon N, oral solution, added to standard therapy. Materials and methods. A prospective open comparative cohort study of the effectiveness of coronavirus infection treatment in children using the standard of care alone and the standard of care with Tonsilgon N was conducted. Group 1 children (n=720) received the standard therapy for COVID-19 and Tonsilgon N oral solution for 10 days, and group 2 patients (n=670) only received the standard therapy for COVID-19. Treatment efficacy was evaluated according to the change of clinical symptoms in the observed patients, the results of SARS-CoV-2 coronavirus RNA detection in nasopharyngeal smears by polymerase chain reaction, the utilization of healthcare services, temporary disability of parents, the economic cost of the disease. Results. Studied patients of both groups had a typical clinical presentation of mild to moderate severity new coronavirus infection. Fatigue (96.599.7%) and sore throat (93.893.9%) were the most frequent symptoms. Posterior pharynx hyperemia was noted slightly less frequently. Low-grade fever was noted in 85.786.6% of the patients, equally often in patients of both groups. The significant therapeutic effect of the herbal medicine containing extract of marshmallow root, chamomile flowers, horsetail herb, walnut leaf, yarrow herb, oak bark, and dandelion herb includes reducing the time of sore throat relief in 93.2% of main group patients. After 10 days of treatment, sore throat persisted only in 6.8% of group 1 and 68.1% of group 2 patients (p=0.0001). These results indicate that Tonsilgon combined with standard of care is a promising way to improve the quality of life of children with the new coronavirus infection. The addition of Tonsilgon in therapy for new coronavirus infection in children shortens the time of acute inflammation resolution and reduces the duration of inflammatory intoxication. The therapy of new coronavirus infection under the provisional guidelines leads to a reduction in the time for clinical recovery and virus elimination in children and adolescents (p=0.0001) and a decrease in the utilization of outpatient healthcare services are observed: 3/4 of Group 1 patients and 1/2 of Group 2 patients (p=0.0001) applied for medical help twice during the observation period, 14.6% of Group 1 patients and 29.1% of Group 2 parents applied for medical help more than 3 times (p=0.0001). Thus, the direct and indirect economic costs of the disease decreased. The lower economic cost for parents of children in Group 1 was due to less need for medication and a lower reduction in family income due to temporary disability compared to those for parents in Group 2 (p=0.0001). No treatment-related adverse events was reported. Conclusion. The above data indicate that Tonsilgon therapy is an affordable way to optimize the treatment of new coronavirus infection in children.